Nitrazepam Lph Labormed

Nitrazepam, the active ingredient in Nitrazepam Lph Labormed, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed through clinical practice to manage insomnia, anxiety disorders, and as adjunctive therapy in certain seizure conditions, primarily in adult patients.

GNH USA supplies Nitrazepam Lph Labormed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. The company maintains rigorous batch testing and traceability to meet EU standards.

Nitrazepam, a benzodiazepine acting on the central nervous system, is used in several therapeutic areas. - Insomnia: Helps initiate and maintain sleep in patients with difficulty sleeping. - Anxiety disorders: Reduces excessive anxiety and tension in generalized anxiety and related conditions. - Seizure disorders: Used as adjunctive therapy for certain refractory seizure types, such as Lennox‑Gastaut syndrome.

Nitrazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: Excessive sleepiness or fatigue. - Dizziness: Light‑headedness or loss of balance. - Memory impairment: Short‑term recall difficulties. - Gastrointestinal upset: Nausea, abdominal discomfort or constipation.

Serious or Rare Side Effects: - Respiratory depression: Marked slowing of breathing, especially with high doses or other CNS depressants. - Dependence and withdrawal: Risk of physical dependence with prolonged use and withdrawal symptoms upon abrupt cessation. - Severe allergic reaction: Rash, itching, swelling, or anaphylaxis. - Paradoxical reactions: Increased agitation, irritability, or seizures.

When prescribing nitrazepam, clinicians should consider several safety precautions to minimize risks. - Assess patient history: Evaluate for prior substance abuse, respiratory disorders, or severe hepatic impairment. - Use lowest effective dose: Initiate therapy at the minimal dose required for symptom control. - Avoid abrupt discontinuation: Gradually taper the dose to prevent withdrawal phenomena. - Monitor for depression: Observe for mood changes, suicidal ideation, or worsening anxiety. - Caution with CNS depressants: Limit concurrent use of alcohol, opioids, or other sedatives. - Store at ambient temperature: Keep tablets in the original container, protect from moisture and light, and store below 25 °C.

Nitrazepam can interact with other medicines, altering its effects or increasing adverse reactions.

Major Interactions (Avoid): - Opioids: Combined use may cause profound respiratory depression and sedation. - Barbiturates: May enhance central nervous system depression and increase overdose risk. - Antifungals (e.g., ketoconazole): Can raise nitrazepam plasma levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): May increase sedation or affect serotonin balance. - Antihistamines: May augment drowsiness and impair psychomotor performance. - Anticonvulsants (phenytoin, carbamazepine): May reduce nitrazepam efficacy by increasing metabolism.